Bill
Bill > HRes787
US HRes787
US HRes787Providing for consideration of the bill (H.B. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.B. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with anoth
summary
Introduced
03/19/2018
03/19/2018
In Committee
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
115th Congress
Bill Summary
Providing for consideration of the bill (H.B. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.B. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes. Sets forth the rule for consideration of the bill (H.B. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.B. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes.
AI Summary
This Resolution sets forth the rules for considering two bills in the House of Representatives. First, it allows for the consideration of H.R. 4566, which aims to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbank financial institutions from certain stress test requirements. The Dodd-Frank Act is a significant piece of legislation enacted after the 2008 financial crisis to regulate the financial industry. Second, it allows for the consideration of H.R. 5247, which would authorize the use of eligible investigational drugs by eligible patients diagnosed with a serious or terminal illness, offering them access to experimental treatments when their condition is dire. For both bills, the Resolution waives points of order that could prevent their consideration, streamlines the amendment process, and limits debate and further motions, ensuring a structured path to a final vote.
Sponsors (1)
Last Action
Motion to reconsider laid on the table Agreed to without objection. (on 03/20/2018)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...